Sylvester Comprehensive Cancer Center

News

Kay and Jack Lombardo with Dr. Asha Pillai, right, at the Woman’s Cancer Association gala.

Dr. Asha Pillai of Sylvester Honored as ‘Cancer Researcher of the Year’

04.10.2018

A pediatric cancer researcher at Sylvester Comprehensive Cancer Center has been honored for groundbreaking immunotherapy studies. Asha Pillai, M.D., a specialist in pediatric hematology-oncology, was named “Cancer Researcher of the Year” by the Woman’s Cancer Association of the University of Miami at its “Dancing for a Cure” Gala.

From left, Karlene Popplewell, clinical assistant, Christine Chen-Shue, RN, Kimberly Delancy, LPN, Kristine Ruche, RN, Marina Rodriguez, LPN, and Barbara Young-Chang, RN.

Sylvester Team Wins Patient Safety Awareness Week Poster Contest

03.26.2018

A team from Sylvester Comprehensive Cancer Center’s Surgical Oncology Department has won the Grand Prize in UHealth’s Patient Safety Awareness Week Poster Contest. The Sylvester department’s entry was one of more than 50 submitted by teams from across the UHealth system. Entries were judged based on creativity, alignment of message, and presentation.

Brian M. Slomovitz, M.D., right, receives the 2018 SOG Presidential Award from Pamela T. Soliman, M.D., M.P.H.

Sylvester Researcher Dr. Brian Slomovitz Receives Award for Best Presentation at Conference

03.21.2018

Brian M. Slomovitz, M.D., co-leader of the Gynecologic Cancers Site Disease Group at Sylvester Comprehensive Cancer Center, received the 2018 Presidential Abstract Award from the Society for Gynecologic Oncology on March 24 during the group’s Annual Meeting on Women’s Cancer in New Orleans. The award was given to Slomovitz for his presentation, which was judged the conference’s best.

Systems Biology and Data Science Symposium attendees. Photo credit: Carlos Enchenique.

Systems Biology and Data Science Symposium Presents Cutting-Edge Advances

03.20.2018

Prominent speakers from Sylvester Comprehensive Cancer Center and other departments and centers at the University of Miami Miller School of Medicine came together with invited experts from the National Institutes of Health and other leading national scientific organizations for an interactive two-day symposium on systems biology and data science preceded by a Data Science Hackathon.

From left, Andrea Williams, Dr. Krishna Komanduri, and Harold Eugene Williams, Andrea’s husband.

Sylvester Comprehensive Cancer Center Celebrates 1,000th Stem Cell Transplant

03.19.2018

When Marcos C. Perez was diagnosed with chronic myeloid leukemia, an uncommon cancer of the blood-producing cells of the bone marrow, he began treatment at Sylvester Comprehensive Cancer Center. After three rounds of chemotherapy, Perez received stem cell transplants to rebuild the white blood cells in his immune system. "I am very positive about my outcome, because so many patients come out of Sylvester as winners."

From left, Erin Kobetz, Ph.D., M.P.H., Peter Tunney, and Stephen D. Nimer, M.D., outside the Game Changer vehicle.

Sylvester’s New Outreach Vehicle a ‘Game Changer’ for Community Cancer Care

03.05.2018

Acclaimed Miami artist Peter Tunney donated his time and talent to help Sylvester Comprehensive Cancer Center launch a “Game Changer” outreach vehicle that will bring cancer screenings and health information to underserved South Florida communities. Using images from Sylvester’s history and mission, Tunney created an original piece of art to “wrap” the mobile van, which was unveiled outside Tunney’s Wynwood studio.

2018 Patient Safety Awareness Week Schedule of Events

03.02.2018

Monday, March 12, begins UHealth’s observance of Patient Safety Awareness Week — an annual national campaign to increase awareness about patient safety among health care professionals and the public. This year’s theme is “Every Day is Patient Safety Day!” — an affirmation of our dedication to creating the safest possible environment for our patients and for each other.

Sylvester Researchers Discover New Pathway Linking Inflammation and Cancer

02.23.2018

A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, collaborating with outside investigators, has discovered a new pathway of inflammation-driven cancer development. Their findings, “Initiation of Inflammatory Tumorigenesis by CTLA4 Insufficiency Due to Type 2 Cytokines,” were published online on January 26 by the Journal of Experimental Medicine.

Barbara A. Vance, Ph.D., CRA.

Dr. Barbara A. Vance to Join Sylvester as Assistant VP and Associate Director for Administration

02.20.2018

Barbara A. Vance, Ph.D., CRA, will join Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine on March 17 as assistant vice president and associate director for administration. Vance will be a senior member of Sylvester’s leadership team, responsible for efficient operations and financial performance, including submission of the National Cancer Institute (NCI) Cancer Center Support Grant.

Team members of the Sylvester Phase 1 clinical trials program.

Sylvester Provides 100 Patients Potentially Life-Saving Treatments in its Phase 1 Trial Program

02.19.2018

Dr. Jaime Merchan is thrilled that Sylvester Comprehensive Cancer Center has reached the milestone number of 100 patients enrolled in a single year in its Phase 1 clinical trials program. The program, which tests new drugs and other novel treatment strategies for advanced solid tumors and hematological malignances, offers these patients something they couldn’t find elsewhere: hope.

Sylvester Comprehensive Cancer Center.

New Analysis: Patients Receiving Chemo for Cancer at ADCC Institutions Have Highest Survival Rates

02.19.2018

Patients treated with chemotherapy for some of the most common types of cancer at Dedicated Cancer Centers have higher survival rates compared to patients treated at other types of hospitals, according to new analysis conducted by Milliman for the Alliance of Dedicated Cancer Centers. Sylvester Comprehensive Cancer Center is one of only 11 members of the Alliance of Dedicated Cancer Centers.

Sylvester Comprehensive Cancer Center.

Sylvester Again Recognized as a Cancer Center of Excellence

02.16.2018

Sylvester Comprehensive Cancer Center has once again been recognized as a Cancer Center of Excellence by the State of Florida — one of just four cancer centers in the state, and the only one in South Florida, to have earned this honor. The designation recognizes providers that exceed service standards and excel in providing quality, comprehensive and patient-centered, coordinated care for cancer patients in Florida.

Adult bone marrow transplant procedure.

Florida Blue Renews Recognition of Sylvester's Adult Bone Marrow Transplant Program

02.13.2018

Florida Blue has renewed its Blue Distinction Center for Transplants designation for the adult bone marrow transplant program at Sylvester Comprehensive Cancer Center. The renewed designation is recognition that the program at Sylvester, part of UHealth – the University of Miami Health System, continues to meet the insurer’s national standards for high quality care and outcomes.

Erin N. Kobetz, Ph.D., M.P.H., Jimmy Patronis, and Stephen D. Nimer, M.D. (from left in center), with fire department representatives.

Florida CFO Jimmy Patronis Tours Sylvester, Praises Firefighters Cancer Initiative

02.09.2018

Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine welcomed the State of Florida’s Chief Financial Officer, Jimmy Patronis, on February 5, giving him a tour of its cancer-fighting technologies. Patronis also met with representatives from more than a dozen of South Florida’s fire departments whose members are collaborating with Sylvester’s Firefighters Cancer Initiative.

From left, Alvaro J. Alencar, M.D., Edmundo Carvalho Mauad, M.D., Ph.D., Gilberto de Lima Lopes, M.D., M.B.A., Sergio Vicente Serrano, M.D., Ph.D., and Joseph D. Rosenblatt, M.D.

Sylvester and Brazil’s Barretos Cancer Hospital Sign Agreement for Collaborative Research

02.06.2018

Sylvester Comprehensive Cancer Center and Barretos Cancer Hospital — one of the most advanced public hospital cancer centers in Brazil — signed a memorandum of understanding on February 2 for wide-ranging collaborative research that may begin by the end of this year. Representatives from Barretos traveled to Miami to sign the agreement, meet with Sylvester researchers and clinicians, and tour Sylvester’s facilities.

From left, Alvaro J. Alencar, M.D., Edmundo Carvalho Mauad, M.D., Ph.D., Gilberto de Lima Lopes, M.D., M.B.A., Sergio Vicente Serrano, M.D., Ph.D., and Joseph D. Rosenblatt, M.D.

Sylvester and Brazil’s Barretos Cancer Hospital Sign Agreement for Collaborative Research

02.06.2018

Sylvester Comprehensive Cancer Center and Barretos Cancer Hospital — one of the most advanced public hospital cancer centers in Brazil — signed a memorandum of understanding on February 2 for wide-ranging collaborative research that may begin by the end of this year. Representatives from Barretos traveled to Miami to sign the agreement, meet with Sylvester researchers and clinicians, and tour Sylvester’s facilities.

Researchers discovered a direct link between G protein-coupled receptors and DNA demethylation.

Link between Environment and DNA May Have Implications for Human Health and Diseases

02.06.2018

Researchers from Sylvester Comprehensive Cancer Center, the John P. Hussman Institute for Human Genomics and The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine, in collaboration with colleagues from other institutions, have discovered a direct link between G protein-coupled receptors (GPCRs) and DNA demethylation — an important finding that could be implicated in human health and diseases.

Felicia Marie Knaul, Ph.D., making her grand rounds presentation.

Dr. Felicia Marie Knaul Addresses Global Women's Cancer Disparities

02.02.2018

Felicia Marie Knaul, Ph.D., a member of Sylvester Comprehensive Cancer Center, professor of public health sciences and director of the University of Miami Institute for Advanced Study of the Americas, described the challenges of global women’s cancer disparities in a grand rounds presentation Jan. 31, part of a lecture series presented by Sylvester’s Global Oncology and International Programs.

Cancer cells.

Going Global to Prevent and Treat Cancer

02.01.2018

“You have cancer” are three of the most frightening words anyone can hear. Your situation is especially perilous if you live in Asia, Africa, Central or South America. According to the World Health Organization, about 60 percent of new cancer cases and 70 percent of cancer deaths occur in those regions. The statistics hit close to home for Gilberto de Lima Lopes Jr., M.D., at Sylvester Comprehensive Cancer Center.

Omar Nelson, Ph.D., running in the Fitbit Miami Marathon.

Sylvester Researcher Runs to Fight Cancer and Bring Communities Together

01.30.2018

Omar Nelson, Ph.D., was giving it his all — “you always save something for the end” — as he crossed the finish line at the Fitbit Miami Marathon on Sunday, January 28. Still, he had good reason to be tired. He had not only completed the grueling 26.2-mile run, but also the 13.1-mile half marathon earlier in the morning — 39.3 miles total. He was the first person ever to run both races back to back.

From left, Enrique A. Mesri, Ph.D., Consul General Marcelo Martin Giusto, Edward Abraham, M.D., and Stephen D. Nimer, M.D.

Argentina Consulate Celebrates Research Collaboration with Sylvester and CFAR

01.24.2018

The Consul General of Argentina in Miami came to the medical campus last week to pay tribute to the consortium of researchers at Sylvester Comprehensive Cancer Center, the University of Miami Center for AIDS Research (CFAR) and institutions in Argentina that was awarded a prestigious National Cancer Institute U54 grant to study AIDS-related malignancies while developing the careers of junior researchers in Argentina.

Sylvester Researchers Recruiting Healthy Women for Ovarian Cancer Early Detection Study

01.17.2018

Often referred to as the “silent killer,” ovarian cancer does not become symptomatic for many women until a late stage of the disease. So any advance that shifts detection earlier, and allows physicians to intervene when survival remains potentially longer, can be welcome news. Sylvester researcher Brian Slomovitz, M.D., and colleagues are conducting a biomarker study to improve early detection, and survival.

Researchers Uncover Evidence of Early Genomic Aberrations in Uveal Melanoma

01.10.2018

Researchers from Sylvester Comprehensive Cancer Center and Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine have uncovered evidence that genomic aberrations in uveal melanoma that lead to metastasis may occur far earlier in tumor evolution than previously believed. The findings fundamentally change the thinking about how this eye cancer progresses.